2023 annual financial data
Celldex Therapeutics 2023 Operating margin
Direct answer
Operating margin was -2,245.27%.
Operating income was -154,542,000 USD and net income was -141,429,000 USD.
Operating cash flow was -107,291,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,883,000 USD
- Operating income
- -154,542,000 USD
- Net income
- -141,429,000 USD
- Operating cash flow
- -107,291,000 USD